References
- Ahlawat S, Kumar P, Mohan H, et al. (2021). Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol 47:254–73.
- Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–18.
- Arévalo-Pérez R, Maderuelo C, Lanao JM. (2020). Recent advances in colon drug delivery systems. J Control Release 327:703–24.
- Azevedo MA, Bourbon AI, Vicente AA, Cerqueira MA. (2014). Alginate/chitosan nanoparticles for encapsulation and controlled release of vitamin B2. Int J Biol Macromol 71:141–6.
- Bansal V, Malviya R, Malaviya T, Sharma PK. (2014). Novel prospective in colon specific drug delivery system. Polim Med 44:109–18.
- Cheng M, Ma D, Zhi K, et al. (2018). Synthesis of biotin-modified galactosylated chitosan nanoparticles and their characteristics in vitro and in vivo. Cell Physiol Biochem 50:569–84.
- Dasgupta Y, Golovine K, Nieborowska-Skorska M, et al. (2018). Drugging DNA repair to target T-ALL cells. Leuk Lymphoma 59:1746–9.
- Descalzo AB, Martínez-Máñez R, Sancenón F, et al. (2006). The supramolecular chemistry of organic-inorganic hybrid materials. Angew Chem Int Ed Engl 45:5924–48.
- Dhital S, Warren FJ, Butterworth PJ, et al. (2017). Mechanisms of starch digestion by α-amylase-structural basis for kinetic properties. Crit Rev Food Sci Nutr 57:875–92.
- Di Meo F, Margarucci S, Galderisi U, et al. (2019). Curcumin, gut microbiota, and neuroprotection. Nutrients 11:2426.
- Grammatikopoulou MG, Gkiouras K, Theodoridis X, et al. (2018). Oral adjuvant curcumin therapy for attaining clinical remission in ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials. Nutrients 10:1737.
- Han W, Xie B, Li Y, et al. (2019). Orally deliverable nanotherapeutics for the synergistic treatment of colitis-associated colorectal cancer. Theranostics 9:7458–73.
- He N, Wang S, Lv Z, et al. (2020). Low molecular weight chitosan oligosaccharides (LMW-COSs) prevent obesity-related metabolic abnormalities in association with the modification of gut microbiota in high-fat diet (HFD)-fed mice. Food Funct 11:9947–59.
- Kobayashi T, Siegmund B, Le Berre C, et al. (2020). Ulcerative colitis. Nat Rev Dis Primers 6:74.
- Li S, He N, Wang L. (2019). Efficiently anti-obesity effects of unsaturated alginate oligosaccharides (UAOS) in high-fat diet (HFD)-fed mice. Mar Drugs 17:540.
- Li S, Wang L, Chen X, et al. (2018). Cloning, expression, and biochemical characterization of two new oligoalginate lyases with synergistic degradation capability. Mar Biotechnol (NY) 20:75–86.
- Li S, Wang L, Jung S, et al. (2020). Biochemical characterization of a new oligoalginate lyase and its biotechnological application in Laminaria japonica degradation. Front Microbiol 11:316.
- Li S, Wang L, Liu B, He N. (2020). Unsaturated alginate oligosaccharides attenuated obesity-related metabolic abnormalities by modulating gut microbiota in high-fat-diet mice. Food Funct 11:4773–84.
- Li S, Wang Y, Li X, et al. (2019). Enhancing the thermo-stability and anti-biofilm activity of alginate lyase by immobilization on low molecular weight chitosan nanoparticles. Int J Mol Sci 20:4565.
- Liu W, Zhai Y, Heng X, et al. (2016). Oral bioavailability of curcumin: problems and advancements. J Drug Target 24:694–702.
- Maity S, Mukhopadhyay P, Kundu PP, Chakraborti AS. (2017). Alginate coated chitosan core–shell nanoparticles for efficient oral delivery of naringenin in diabetic animals-an in vitro and in vivo approach. Carbohydr Polym 170:124–32.
- Manju S, Sreenivasan K. (2011). Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. J Colloid Interface Sci 359:318–25.
- Mukhopadhyay P, Chakraborty S, Bhattacharya S, et al. (2015). pH-sensitive chitosan/alginate core–shell nanoparticles for efficient and safe oral insulin delivery. Int J Biol Macromol 72:640–8.
- Mura S, Nicolas J, Couvreur P. (2013). Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12:991–1003.
- Nelson KM, Dahlin JL, Bisson J, et al. (2017). The essential medicinal chemistry of curcumin. J Med Chem 60:1620–37.
- Park C, Kim H, Kim S, Kim C. (2009). Enzyme responsive nanocontainers with cyclodextrin gatekeepers and synergistic effects in release of guests. J Am Chem Soc 131:16614–5.
- Peng X, Wilken SE, Lankiewicz TS, et al. (2021). Genomic and functional analyses of fungal and bacterial consortia that enable lignocellulose breakdown in goat gut microbiomes. Nat Microbiol 6:499–511.
- Perše M, Cerar A. (2012). Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012:718617.
- Pushpamalar J, Sathasivam T, Gugler MC. (2021). Hydrogel beads of natural polymers as a potential vehicle for colon-targeted drug delivery. Methods Mol Biol 2211:171–82.
- Rivera MC, Pinheiro AC, Bourbon AI, et al. (2015). Hollow chitosan/alginate nanocapsules for bioactive compound delivery. Int J Biol Macromol 79:95–102.
- Ruiz A, Ma G, Seitsonen J, et al. (2020). Encapsulated doxorubicin crystals influence lysolipid temperature-sensitive liposomes release and therapeutic efficacy in vitro and in vivo. J Control Release 328:665–78.
- Ruiz-Hernández E, Baeza A, Vallet-Regí M. (2011). Smart drug delivery through DNA/magnetic nanoparticle gates. ACS Nano 5:1259–66.
- Sacks D, Baxter B, Campbell BCV, et al. (2018). Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke 13:612–32.
- Sadeghi N, Mansoori A, Shayesteh A, Hashemi SJ. (2020). The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis. Phytother Res 34:1123–33.
- Sadeghi N, Mansoori A, Shayesteh A, Hashemi SJ. (2020). The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis. Phytother Res 34:1123–33.
- Schroeder A, Goldberg MS, Kastrup C, et al. (2012). Remotely activated protein-producing nanoparticles. Nano Lett 12:2685–9.
- Shabbir U, Rubab M, Daliri EB, et al. (2021). Curcumin, quercetin, catechins and metabolic diseases: the role of gut microbiota. Nutrients 13:206.
- Song J, Ma Q, Hu M, et al. (2018). The inhibition of mir-144-3p on cell proliferation and metastasis by targeting TOP2A in HCMV-positive glioblastoma cells. Molecules 23:3259.
- Sorasitthiyanukarn FN, Muangnoi C, Ratnatilaka Na Bhuket P, et al. (2018). Chitosan/alginate nanoparticles as a promising approach for oral delivery of curcumin diglutaric acid for cancer treatment. Mater Sci Eng C Mater Biol Appl 93:178–90.
- Tasciotti E. (2018). Smart cancer therapy with DNA origami. Nat Biotechnol 36:234–5.
- Thai H, Thuy Nguyen C, Thi Thach L, et al. (2020). Characterization of chitosan/alginate/lovastatin nanoparticles and investigation of their toxic effects in vitro and in vivo. Sci Rep 10:909.
- Tønnesen HH, Karlsen J. (2002). Alginate in drug delivery systems. Drug Dev Ind Pharm 28:621–30.
- Wang QS, Wang GF, Zhou J, et al. (2016). Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis. Int J Pharm 515:176–85.
- Xiong MH, Bao Y, Yang XZ, et al. (2012). Lipase-sensitive polymeric triple-layered nanogel for "on-demand" drug delivery. J Am Chem Soc 134:4355–62.
- Zhang G, Yang M, Cai D, et al. (2014). Composite of functional mesoporous silica and DNA: an enzyme-responsive controlled release drug carrier system. ACS Appl Mater Interfaces 6:8042–7.